NewsRoom Articles - Page 20 of 154 - PsychedelicNewsWire (PNW)

ThursdayNov 02, 2023 2:49 pm

Psychedelic Advocates Say They Have Enough Signatures for Legislative Action

Supporters of a campaign to legalize psychedelics in Massachusetts believe they have gathered enough signatures to compel legislators to consider their initiative. If this is not successful, the group plans to put the psychedelics legalization measure on next year’s ballot. This move comes less than two months after the group, called Massachusetts for Mental Health Options, started its petition. The campaign, which is backed by New Approach, has revealed that it has verified more than 75,000 signatures from registered voters in the state. This milestone comes weeks after activists decided to pursue one of the pair of psychedelic initiatives the…

WednesdayNov 01, 2023 11:17 am

VR Widens Possibilities for Psychedelic-Assisted Therapy

Recent advancements in virtual technology may have applications in psychedelic-assisted therapy. Both are relatively new fields that have attracted lots of attention in recent years thanks to their potentially game-changing applications. Psychedelic-assisted therapy has shown it has the potential to offer long-term relief against a variety of mental-health disorders with few if any side effects. Researchers have found that virtual technology may enhance psychedelic-assisted therapy by simulating the visual phenomenology of psychedelic states. With both fields in their infancy, scientists are focusing their efforts on using virtual reality (VR) as a companion to psychedelic-assisted therapy or a potential nondrug alternative.…

TuesdayOct 31, 2023 2:44 pm

Seattle Doctor Scores Court Win Against DEA Over Refusal to Reschedule Psilocybin

Last week, a federal appeals court ruled against the U.S. Drug Enforcement Agency (DEA) in a lawsuit filed by a doctor in Washington state who sought to get psilocybin rescheduled. The U.S. Court of Appeals for the Ninth Circuit stated that the agency hadn’t explained its reasoning when it denied Dr. Sunil Aggarwal’s petition, and the court ordered the DEA to provide a more complete justification. In its letter of denial, the DEA stated that a precondition to transferring a substance from Schedule I to II under the Controlled Substance Act was for the U.S. Food and Drug Administration (FDA)…

MondayOct 30, 2023 11:55 am

Study Suggests Methamphetamine More Helpful for Social Bonding Compared to MDMA

A recent study on methamphetamines and MDMA has produced interesting findings on the two drugs and their potential association with human connection. Researchers found that both MDMA and methamphetamines can enhance feelings of closeness and connectedness, but methamphetamines seemed to deliver stronger long-term benefits on social bonding compared to the psychedelic. While both methamphetamines and MDMA are psychoactive in nature, they affect people in wildly different ways. MDMA (also known as molly or ecstasy) is a hallucinogenic with prosocial and empathogenic properties. MDMA users often report increased feelings of emotional closeness and trust, which has led to increased MDMA use…

FridayOct 27, 2023 12:10 pm

Study Shows Ketamine Acts Against TRD within Four Hours

Researchers from Sorbonne University have found that ketamine can reduce depression symptoms in patients with treatment-resistant depression (TRD) just four hours after infusion. Compared to healthy controls, patients with TRD reported feeling more optimistic a few hours after ketamine infusion, indicating that the psychedelic may have potent and fast-acting mental health benefits. Prior studies have suggested that ketamine can alleviate depressive symptoms and reduce suicidal thoughts in some people, but this recent study sought to understand exactly how ketamine delivered its antidepression effects. Hugo Bottemanne from Sorbonne University’s Paris Brain Institute said several pharmacological studies have shown ketamine has the…

ThursdayOct 26, 2023 3:55 pm

Study Suggests Psilocybin Could Manage Childhood Trauma

A recent Canadian study has suggested that psilocybin, the main hallucinogenic agent in magic mushrooms, may ease the psychological distress associated with childhood trauma. Researchers say the psychedelic seemed to offer “particularly strong benefits” to individuals who faced extremely severe adversity during childhood. Led by a team of researchers from Athabasca University, the University of British Columbia, Simon Fraser University and the University of Michigan, the study involved assessing the childhood trauma experiences of 1,249 Canadians aged 15 years and older. The researchers asked participants about any prior psilocybin use, when they last took the psychedelic and the strength and…

WednesdayOct 25, 2023 1:19 pm

Hearings Commence for Lawsuit Denying Psilocybin Scheduling Change Request

A federal appeals court panel has begun hearing arguments in a case involving a Seattle doctor who sued the U.S. Drug Enforcement Administration for denying his patients access to psilocybin therapy and who is now asking the federal government to reschedule the psychedelic. The suit is part of the Seattle-based doctor’s efforts to expand psilocybin access to terminally ill patients to treat anxiety and end-of-life depression. Psychedelics such as psilocybin, or magic mushrooms, are all the rage these days thanks to a growing body of research indicating they have potent mental health benefits. Dr. Sunil Aggarwal wanted to use psilocybin,…

TuesdayOct 24, 2023 12:47 pm

Why Some People Get Anxious After Taking Psilocybin Mushrooms

Advances in psychedelic research have found that psilocybin mushrooms may be able to treat mental conditions such as depression, cancer-related psychological stress and substance use disorders. Psilocybin-assisted therapy typically involves going through a guided psilocybin experience and using talk therapy to integrate the insights and realizations made during the experience into everyday life. This kind of treatment has proven that it can alleviate mental disorders including depression, but many patients aren’t keen on going through what might be an hours long psilocybin trip. While some people simply aren’t comfortable with the idea of being under the influence of a drug,…

MondayOct 23, 2023 1:02 pm

Harvard Receives $16M Donation for Psychedelics Study Focusing on Culture, Society

A former Tesla director has donated $16 million to Harvard University to fund psychedelic research in culture and society. Antonio Gracias is donating $16 million to the academic institution via the Gracias Family Foundation to further psychedelic research in a newly established Study of Psychedelics in Society and Culture at Harvard University. The study will draw researchers from Harvard Law School, Harvard Divinity School and the Faculty of Arts and Sciences. The study will focus on producing state-of-the-art scholarship as well as convening faculty, experts and students to discuss the implications of the burgeoning therapeutic psychedelics industry. A recent surge…

FridayOct 20, 2023 3:40 pm

Studies Show Growing Popularity of LSD Among Company Executives

Recent study findings published in the “Substance Use & Misuse” journal indicate that the use of psychedelics such as LSD is becoming especially prevalent among business managers in managerial positions. The study found that while there has been a general increase in psychedelic interest in the public, company executives seem to be using lysergic acid diethylamide (LSD) at high rates. Psychedelics have enjoyed significant attention from public and scientific circles in recent years thanks to a growing body of research connecting hallucinogens such as LSD, psilocybin, ayahuasca and MDMA to a wide range of mental health benefits. Research has found…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000